NZ520482A - Selective N-acylation of A82846 glycopeptide analogs that are ueful for treating staphylococcal infection - Google Patents

Selective N-acylation of A82846 glycopeptide analogs that are ueful for treating staphylococcal infection

Info

Publication number
NZ520482A
NZ520482A NZ520482A NZ52048201A NZ520482A NZ 520482 A NZ520482 A NZ 520482A NZ 520482 A NZ520482 A NZ 520482A NZ 52048201 A NZ52048201 A NZ 52048201A NZ 520482 A NZ520482 A NZ 520482A
Authority
NZ
New Zealand
Prior art keywords
ueful
acylation
selective
staphylococcal infection
treating staphylococcal
Prior art date
Application number
NZ520482A
Other languages
English (en)
Inventor
Richard Craig Thompson
Stephen Charles Wilkie
Mark James Zweifel
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NZ520482A publication Critical patent/NZ520482A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K9/00Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K9/00Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/006Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
    • C07K9/008Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NZ520482A 2000-02-11 2001-02-12 Selective N-acylation of A82846 glycopeptide analogs that are ueful for treating staphylococcal infection NZ520482A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18168300P 2000-02-11 2000-02-11
PCT/US2001/004540 WO2001058933A2 (en) 2000-02-11 2001-02-12 Selective n-acylation of a82846 glycopeptide analogs

Publications (1)

Publication Number Publication Date
NZ520482A true NZ520482A (en) 2004-12-24

Family

ID=22665319

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ520482A NZ520482A (en) 2000-02-11 2001-02-12 Selective N-acylation of A82846 glycopeptide analogs that are ueful for treating staphylococcal infection

Country Status (17)

Country Link
US (1) US7365053B2 (https=)
EP (1) EP1254164B1 (https=)
JP (1) JP2003522197A (https=)
KR (1) KR100796079B1 (https=)
CN (1) CN1422279A (https=)
AT (1) ATE308560T1 (https=)
AU (2) AU3818001A (https=)
BR (1) BR0108268A (https=)
CA (1) CA2399640A1 (https=)
CZ (1) CZ20022722A3 (https=)
DE (1) DE60114567T2 (https=)
MX (1) MXPA02007739A (https=)
NO (1) NO20023761L (https=)
NZ (1) NZ520482A (https=)
PL (1) PL356966A1 (https=)
WO (1) WO2001058933A2 (https=)
ZA (1) ZA200206360B (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1534316A2 (en) * 2002-08-30 2005-06-01 K.U. Leuven Research and Development Glycopeptide antibiotics and semisynthetic derivatives thereof and their use as antiviral agents
US8088387B2 (en) * 2003-10-10 2012-01-03 Immunogen Inc. Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates, and methods of making said conjugates
CN1557479A (zh) * 2004-01-16 2004-12-29 深圳市海王英特龙生物技术股份有限公 干扰素脂质体乳膏
US7632918B2 (en) 2005-02-28 2009-12-15 Novartis Vaccines And Diagnostics, Inc. Semi-synthetic glycopeptides with antibiotic activity
GB2577420B (en) 2017-05-22 2022-07-06 Insmed Inc Glycopeptide derivative compounds and uses thereof
CN108484719A (zh) * 2018-01-19 2018-09-04 四川大学 硫酸酯化十二指肠糖肽制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4698327A (en) * 1985-04-25 1987-10-06 Eli Lilly And Company Novel glycopeptide derivatives
US4643987A (en) * 1985-08-14 1987-02-17 Eli Lilly And Company Modified glycopeptides
US4639433A (en) * 1985-08-14 1987-01-27 Eli Lilly And Company Glycopeptide derivatives
CA2031803C (en) * 1989-12-13 2001-05-29 Ramakrishnan Nagarajan Improvements in or relating to glycopeptide deriveratives
US5840684A (en) * 1994-01-28 1998-11-24 Eli Lilly And Company Glycopeptide antibiotic derivatives
WO1999056760A1 (en) * 1998-05-01 1999-11-11 Eli Lilly And Company N1-modified glycopeptides

Also Published As

Publication number Publication date
WO2001058933A2 (en) 2001-08-16
AU3818001A (en) 2001-08-20
EP1254164B1 (en) 2005-11-02
JP2003522197A (ja) 2003-07-22
US7365053B2 (en) 2008-04-29
EP1254164A2 (en) 2002-11-06
DE60114567D1 (de) 2005-12-08
NO20023761D0 (no) 2002-08-08
NO20023761L (no) 2002-08-26
CZ20022722A3 (cs) 2003-01-15
CN1422279A (zh) 2003-06-04
CA2399640A1 (en) 2001-08-16
KR20020073546A (ko) 2002-09-26
WO2001058933A3 (en) 2002-02-14
ATE308560T1 (de) 2005-11-15
HK1049171A1 (en) 2003-05-02
ZA200206360B (en) 2003-11-10
MXPA02007739A (es) 2002-10-11
US20070219123A1 (en) 2007-09-20
AU2001238180B2 (en) 2005-12-15
PL356966A1 (en) 2004-07-12
BR0108268A (pt) 2003-03-05
DE60114567T2 (de) 2006-07-27
AU2001238180B8 (en) 2006-07-27
KR100796079B1 (ko) 2008-01-21

Similar Documents

Publication Publication Date Title
NZ529881A (en) Capsular polysaccharide solubilisation and combination vaccines
AU2002306164A1 (en) Composition and method for improving plant growth
AU2002335788A1 (en) Flexible processing apparatus for isolating and purifying viruses, soluble proteins and peptides from plant sources
AU2002329885A1 (en) Atmospheric pressure wafer processing reactor having an internal pressure control system and method
PL393938A1 (pl) Środek chwastobójczy, sposób zwalczania niepożądanego wzrostu i zastosowanie kompozycji
CA2031803A1 (en) Improvements in or relating to glycopeptide deriveratives
MY138285A (en) Fab i inhibitors
FR12C0004I1 (https=)
TR200400072T4 (tr) Novel Biarylcarboxamides Biarylcarboxamide Nouveaux Biarylcarboxamides
AU4473300A (en) Hair transplantation method and apparatus
ZA200108215B (en) Compositions and methods for treatment of staphylococcal infection.
CA2369598A1 (fr) Procede de maintien en position d'une piece dans un poste d'assemblage
NZ520482A (en) Selective N-acylation of A82846 glycopeptide analogs that are ueful for treating staphylococcal infection
HUP0300585A3 (en) Process for the use of azalide antibiotic compositions for treating or preventing a bacterial or protozoal infection in mammals
WO2001040280A3 (en) Composition and method for treating a microbial infection
AU2002320510A1 (en) Method of improving plant growth
AU2002324753A1 (en) Composition and method for treating viral infection
GB0117183D0 (en) Method and apparatus for growing plants
AU3439799A (en) Immunization against and treatment for infection by (h.pylori)
AU2002301265A1 (en) Plant growing method and apparatus
AU2003231959A1 (en) Method and compound for the prophylaxis or treatment of an immunodeficiency condition, such as aids
GB9920048D0 (en) Epitaxial growth method of III-nitride semiconductors
AU5840301A (en) Method for the processing of plant material
AU7467901A (en) System for culturing marine life and growth device for this purpose
AU2001245670A1 (en) Materials and methods for the regeneration of plants from cultured plant tissue

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)
PSEA Patent sealed
RENW Renewal (renewal fees accepted)